Overview
Dr. Chida is the Director of the Osler Medical Residency She is the Myron L. Weisfeldt Professor of Medicine and is an assistant professor in the Division of Infectious Diseases. Prior to becoming Program Director of the Osler Residency in 2021, Dr. Chida served as the associate director of the Infectious Diseases Fellowship Training Program for 6 years. She was also co-director of the Medical Education Pathway of the Johns Hopkins Bayview and Osler Internal Medicine Residency Programs, and was a clinical coach in Barker Firm of the Osler Program. Dr. Chida has served on national education committees for the ACGME and the Infectious Disease Society of America, and is a Fellow of the Infectious Disease Society of America. Dr. Chida received undergraduate degrees in English and Psychology from the University of Florida. She then earned her medical degree and masters of science in public health from the University of Miami Miller School of Medicine. She completed her residency in internal medicine at the University of Miami/Jackson Memorial Hospital, where she also served as a chief medical resident. She came to Hopkins to pursue fellowship in infectious diseases, and in 2016, she joined the faculty in the Division of Infectious Diseases. Dr. Chida’s interests include career development for physicians-in-training, the advancement of women in medicine, and how to best train residents and fellows in HIV care. Clinically she focuses on HIV care and general infectious diseases.
Her clinical expertise encompasses HIV/AIDS, Asymptomatic Bacteriuria, Myelitis, and AIDS Dysmorphic Syndrome.
Dr. Chida is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 22 peer reviewed articles. Dr. Chida is currently accepting new patients.
Graduate Year
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1717 East Monument Street, Park Building, Ground Level, Park Building, Ground Level, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever. Dr. Durbin is board certified in American Board Of Internal Medicine. Dr. Durbin is currently accepting new patients.
The Johns Hopkins Hospital
Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B. Dr. Sulkowski is board certified in American Board Of Internal Medicine. Dr. Sulkowski is currently accepting new patients.
The Johns Hopkins Hospital
John Baddley is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Baddley is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia. Dr. Baddley is board certified in American Board Of Internal Medicine. Dr. Baddley is currently accepting new patients.
Frequently Asked Questions about Dr. Natasha M. Chida
How do I make an appointment with Dr. Natasha M. Chida?
You can book an appointment with Dr. Natasha M. Chida by calling their office at 410-955-1725. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Natasha M. Chida a top-rated expert for HIV/AIDS?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Natasha M. Chida is classified as an Experienced expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Natasha M. Chida specialize in?
While Dr. Natasha M. Chida is a Infectious Disease, they have specific expertise in HIV/AIDS, Asymptomatic Bacteriuria, and Myelitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.
Does Dr. Natasha M. Chida participate in research or clinical trials?
Yes. Dr. Natasha M. Chida has published 22 articles and abstracts on conditions like HIV/AIDS. You can view a list of Dr. Natasha M. Chida's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Natasha M. Chida accept my insurance?
Dr. Natasha M. Chida accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 410-955-1725 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AIDS Dementia ComplexDr. Chida isExperienced. Learn about AIDS Dementia Complex.
- AIDS Dysmorphic SyndromeDr. Chida isExperienced. Learn about AIDS Dysmorphic Syndrome.
- Asymptomatic BacteriuriaDr. Chida isExperienced. Learn about Asymptomatic Bacteriuria.
- HIV/AIDSDr. Chida isExperienced. Learn about HIV/AIDS.
- MyelitisDr. Chida isExperienced. Learn about Myelitis.
- SepsisDr. Chida isExperienced. Learn about Sepsis.
- Severe Acute Respiratory Syndrome (SARS)